Rainbow Children’s Medicare has granted 5,660 stock options to its eligible employees under its Employee Stock Option Scheme 2025 (ESOP 2025) as approved by the Nomination and Remuneration Committee (NRC) on November 13, 2025. These options vest after a minimum period of 1 year and can be exercised within 2 years of vesting.
ESOP Grant Details
Rainbow Children’s Medicare has granted 5,660 stock options to its eligible employees under the Employee Stock Option Scheme 2025 (“ESOP 2025”). The decision was made during the Nomination and Remuneration Committee (“NRC”) meeting held on November 13, 2025.
Key Scheme Highlights
The granted stock options can be converted into an equivalent number of equity shares. The vesting period for these options starts after a minimum period of one year, with a maximum vesting period extending up to ten years from the grant date. After vesting, employees have up to two years to exercise their options. The exercise price was determined with a discount of no more than 20% on the latest available closing price on the National Stock Exchange (NSE) as of November 12, 2025.
Cancellation of Options
Notably, 17,680 stock options granted earlier, as of the Nomination and Remuneration Committee meeting held on July 26, 2025, have been cancelled due to the exit of respective employees before their vesting period could be completed.
Source: BSE
